CALITHERA BIOSCIENCES INC's ticker is CALA and the CUSIP is 13089P101. A total of 93 filers reported holding CALITHERA BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,284,000 | +257.7% | 190,501 | +112.5% | 0.00% | – |
| Q4 2018 | $359,000 | -55.9% | 89,631 | -42.2% | 0.00% | – |
| Q3 2018 | $814,000 | +44.3% | 155,182 | +37.5% | 0.00% | – |
| Q2 2018 | $564,000 | -30.3% | 112,890 | -12.1% | 0.00% | -100.0% |
| Q1 2018 | $809,000 | -54.7% | 128,358 | -39.9% | 0.00% | 0.0% |
| Q4 2017 | $1,784,000 | -40.1% | 213,663 | +13.0% | 0.00% | -50.0% |
| Q3 2017 | $2,979,000 | +9.2% | 189,115 | +3.0% | 0.00% | 0.0% |
| Q2 2017 | $2,727,000 | +1128.4% | 183,620 | +370.2% | 0.00% | – |
| Q1 2016 | $222,000 | -25.8% | 39,055 | 0.0% | 0.00% | – |
| Q4 2015 | $299,000 | +41.0% | 39,055 | 0.0% | 0.00% | – |
| Q3 2015 | $212,000 | -24.0% | 39,055 | 0.0% | 0.00% | – |
| Q2 2015 | $279,000 | +13.0% | 39,055 | +160.1% | 0.00% | – |
| Q1 2015 | $247,000 | -18.5% | 15,018 | 0.0% | 0.00% | – |
| Q4 2014 | $303,000 | – | 15,018 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,426,702 | $5,072,000 | 4.00% |
| BVF INC/IL | 7,299,331 | $15,256,000 | 0.57% |
| TSP Capital Management Group, LLC | 463,500 | $969,000 | 0.32% |
| Tibra Equities Europe Ltd | 158,500 | $331,000 | 0.10% |
| Parkman Healthcare Partners LLC | 100,628 | $210,000 | 0.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31,382 | $66,000 | 0.03% |
| FEDERATED HERMES, INC. | 6,668,978 | $13,938,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 108,111 | $226,000 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 133,580 | $279,000 | 0.02% |
| XTX Topco Ltd | 31,242 | $65,000 | 0.02% |